MRKR vs WTW · rev $751.7K vs P/E 15, rev $4.88B
Marker Therapeutics Inc (MRKR) versus Willis Towers Watson PLC (WTW) — a side-by-side from cached financials, not a winner call.
Marker Therapeutics Inc (MRKR) is a biotechnology company listed on US.
Willis Towers Watson PLC (WTW) is a insurance brokers company listed on NASDAQ.
Latest reported MRKR revenue for 2026-03-31 was $751.7K. Net income was -$3.2M. Revenue was down 69.2% from 2025-09-30 to 2026-03-31. MRKR currently screens at market cap $25.3M.
Latest reported WTW revenue for 2026-06-30 was $4.88B. Net income was $526.0M. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
MRKR currently screens at market cap $25.3M. WTW currently screens at market cap $24.41B and trailing P/E 15.2.
Not investment advice. Open the MRKR and WTW stock pages for the full models.
Not investment advice.